Perfusio
Greenville, US · Founded 2014 · North Carolina corporation · 1 known investors
Find your way into Perfusio
519 people in our graph share verified history with the Perfusio team — schools, employers, funds. One of them is your warm intro.
Ryan Rossunlockedknows Cheng Chen · together at East Carolina University (overlapped)
knows the team · via East Carolina University
×4knows the team · via University of Rochester
×6knows the team · via Harvard Business School Online
Founders & leadership
RB
RICHARD BALOTExecutive
JA

JOFFRE ALVAREZChief Operating OfficerChief Operating Officer of Perfusio, Joffre Alvarez brings over 15 years of medical device industry experience including prior roles at BIONIK and Olympus, with expertise in engineering, project management, quality assurance, and regulatory compliance. He holds a PMP certification.
JC
Jeffery C. BashamExecutive
PG

CC

Cheng ChenChief Science and Technology OfficerDr. Cheng Chen holds a PhD in Biomedical Physics from East Carolina University and has worked in optical imaging and medical device development; he is Co-founder and Chief Science and Technical Officer of Perfusio, which develops real-time blood flow and perfusion imaging platforms, and holds over fifteen issued or allowed patents with additional applications pending.
TB
Thomas Bruce FergusonNamed on SEC filing
Board
GM
GEORGE MCGINNBoard director
WP
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.4M disclosed across 6 rounds · 2015–2024
▶$2.2MraisedDec 2024 · 36 investors · Other Health CareRule 506(b)
▶$2.2MraisedDec 2024 · 36 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- GEORGE MCGINNDirector
- RICHARD BALOTExecutive Officer, Director
- JOFFRE ALVAREZExecutive Officer
- WILLIAM PHILLIP HODGESDirector
- Offering amount
- $4M
- Amount sold
- $2.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$1.6MraisedJan 2023 · 26 investors · Other Health CareRule 506(b)
▶$1.6MraisedJan 2023 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID LAVANCEDirector
- STEVE TAYLORDirector
- RICHARD BALOTDirector
- CHENG CHENExecutive Officer
- GEORGE MCGINNDirector
- WILLIAM PHILLIP HODGESExecutive Officer, Director
- KENICHI MATSUMURADirector
- THOMAS BRUCE FERGUSONDirector
- PETER M. GEIGERExecutive Officer
- Offering amount
- $2.6M
- Amount sold
- $1.6M
- First sale
- Jul 2022
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$5MraisedSep 2021 · 16 investors · Other Health CareRule 506(b)
▶$5MraisedSep 2021 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD BALOTDirector
- KENICHI MATSUMURADirector
- THOMAS BRUCE FERGUSONDirector
- STEVE TAYLORDirector
- WILLIAM PHILLIP HODGESDirector
- GEORGE MCGINNDirector
- CHENG CHENDirector
- MONTE B. TUCKERExecutive Officer, Director
- PETER M. GEIGERExecutive Officer
- DAVID LAVANCEDirector
- MIKE SNOWDirector
- Offering amount
- $8.5M
- Amount sold
- $5M
- First sale
- Aug 2020
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$868.7KraisedMar 2019 · 18 investors · Other Health CareRule 506(b)
▶$868.7KraisedMar 2019 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- THOMAS BRUCE FERGUSONDirector
- WILLIAM PHILLIP HODGESDirector
- KENICHI MATSUMURADirector
- JEFFERY BASHAMExecutive Officer, Director
- PETER GEIGERExecutive Officer
- STEVE TAYLORDirector
- RICHARD BALOTDirector
- CHENG CHENDirector
- Offering amount
- $1M
- Amount sold
- $868.7K
- First sale
- Mar 2019
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
▶$3.5MraisedSep 2017 · 1 investors · Other Health CareRule 506(b)
▶$3.5MraisedSep 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- KENICHI MATSUMURADirector
- STEVE TAYLORDirector
- CHENG CHENDirector
- THOMAS BRUCE FERGUSONDirector
- JEFFERY BASHAMExecutive Officer, Director
- PETER GEIGERExecutive Officer
- WILLIAM PHILLIP HODGESDirector
- RICHARD BALOTDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Sep 2017
- Incorporated
- Corporation, North Carolina, 2014
- Federal exemptions
- 06b
▶$3.2MraisedMar 2017 · 25 investors · Other Health CareRule 506(b)
▶$3.2MraisedMar 2017 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffery C. BashamExecutive Officer
- William Phillip HodgesDirector
- Peter GeigerExecutive Officer
- Cheng ChenExecutive Officer
- Thomas Bruce FergusonDirector
- Offering amount
- $3.5M
- Amount sold
- $3.2M
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, North Carolina, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Perfusio's investors?
- Perfusio's investors include Nano Ventures.
- How much funding has Perfusio raised?
- Perfusio has disclosed $16.4M raised across 6 rounds.
- Where is Perfusio headquartered?
- Perfusio is headquartered in Greenville, US.
